Gregory Dennis, M.D., has been named vice president of global product development at Pharmaceutical Product Development, LLC (PPD). In this role, Dr. Dennis serves as therapeutic area head, providing medical and scientific expertise for rheumatology, immunology and inflammatory diseases.

Dr. Dennis comes to PPD from UCB, where he served as head of immunology for U.S. medical affairs and participated in guiding compounds through the regulatory approval process. Previously, he held leadership roles at Human Genome Sciences, MedImmune and the National Institutes of Health. He retired from the U.S. Army Medical Corps as a colonel, chief of rheumatology and consultant to the army surgeon general.

“Dr. Dennis brings extensive product development and commercialization experience and will play a key role in helping clients plan and address critical drug development challenges,” said Rob Dow, M.B.Ch.B., F.R.C.P. (Edin), F.F.P.M., global head of medical affairs for PPD. “His background with biopharma companies and government agencies adds value to PPD’s global clinical trial experience in a variety of rheumatology, immunology and inflammatory areas, including osteoarthritis, rheumatoid arthritis, gout, lupus and psoriasis.”